Status:

RECRUITING

Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study

Lead Sponsor:

Charlotte Runge

Conditions:

Nerve Block

Opioid Tolerance

Eligibility:

All Genders

18-84 years

Phase:

NA

Brief Summary

Do peripheral nerve blocks work shorter if you are on opioids? Background: Peripheral nerve blocks effectively alleviate postoperative pain. Animal studies and human research indicate that opioid to...

Eligibility Criteria

Inclusion

  • Inclusion criteria for opioid group
  • Age \> 18 years old
  • ASA 1-3
  • Chronic pain, defined as persisting pain for more than three months
  • Daily use of more than 60 mg of morphine equivalent in more than 7 days
  • Legally competent and able to give informed consent
  • Inclusion criteria for the opioid naive control group
  • Age \> 18 years old
  • ASA 1-3
  • No use of opioids within 30 days prior to participation
  • Legally competent and able to give informed consent
  • Exclusion Criteria:
  • Age \> 84 years old
  • Volunteers who cannot cooperate with the study
  • Volunteers who cannot understand or speak Danish
  • Allergy to the lidocaine or the preservatives used in the study
  • Alcohol or drug abuse other than opioids
  • Peripheral neuropathy at the upper limb non-dominant arm
  • Pathology or previous major surgery to the upper limb
  • Active signs of infection in the cutaneous area of injection
  • Pregnancy at the time of the trial
  • Partial or complete 2nd or 3rd degree atrioventricular heart block without a pacemaker
  • Severe liver disease
  • Severe kidney disease and reduced kidney function (eGFR below 30 mL/min)
  • Daily treatment with drugs that are structurally related to local analgesics or class IB antiarrhythmics, as the toxic effects are additive
  • Daily treatment with class III antiarrhythmics e.g., amiodarone.

Exclusion

    Key Trial Info

    Start Date :

    June 17 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2025

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06488768

    Start Date

    June 17 2024

    End Date

    May 1 2025

    Last Update

    July 5 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Silkeborg Regional Hospital

    Silkeborg, Denmark, 8600